HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Abstract
Evidence that brain glutamatergic activity is pathologically elevated in bipolar disorder suggests that mood stabilizers are therapeutic in the disease in part by downregulating glutamatergic activity. Such activity can involve the second messenger, arachidonic acid (AA, 20:4n - 6). We tested this hypothesis with regard to valproic acid (VPA), when stimulating glutamatergic N-methyl-D: -aspartate (NMDA) receptors in rat brain and measuring AA and related responses. An acute subconvulsant dose of NMDA (25 mg/kg i.p.) or saline was administered to unanesthetized rats that had been treated i.p. daily with VPA (200 mg/kg) or vehicle for 30 days. Quantitative autoradiography following intravenous [1-(14)C]AA infusion was used to image regional brain AA incorporation coefficients k*, markers of AA signaling. In chronic vehicle-pretreated rats, NMDA compared with saline significantly increased k* in 41 of 82 examined brain regions, many of which have high NMDA receptor densities, and also increased brain concentrations of the AA metabolites, prostaglandin E(2) (PGE(2)) and thromboxane B(2) (TXB(2)). VPA pretreatment reduced baseline concentrations of PGE(2) and TXB(2), and blocked the NMDA induced increases in k* and in eicosanoid concentrations. These results, taken with evidence that carbamazepine and lithium also block k* responses to NMDA in rat brain, suggest that mood stabilizers act in bipolar disorder in part by downregulating glutamatergic signaling involving AA.
AuthorsMireille Basselin, Lisa Chang, Mei Chen, Jane M Bell, Stanley I Rapoport
JournalNeurochemical research (Neurochem Res) Vol. 33 Issue 11 Pg. 2229-40 (Nov 2008) ISSN: 1573-6903 [Electronic] United States
PMID18461450 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Arachidonic Acid
  • Thromboxane B2
  • Valproic Acid
  • N-Methylaspartate
  • Dinoprostone
Topics
  • Animals
  • Arachidonic Acid (metabolism)
  • Autoradiography
  • Behavior, Animal
  • Brain (drug effects, metabolism)
  • Dinoprostone (metabolism)
  • Male
  • N-Methylaspartate (metabolism)
  • Rats
  • Rats, Inbred F344
  • Signal Transduction (drug effects)
  • Thromboxane B2 (metabolism)
  • Valproic Acid (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: